Physician profile
Julia Youssef
NPI 1285195404
$6,251.56
in general payments reported to CMS, 2019-2025
22 companies · $628 in 2025
The $628 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $146 · 2024: $5,477 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,276 · Travel and Lodging: $1,599 · Food and Beverage: $1,376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,275.98 |
| Travel and Lodging | $1,599.33 |
| Food and Beverage | $1,376.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,677.52 | 2024 | |
| Astellas Pharma US INC | $604.38 | 2024-2025 | Veozah |
| Shield Therapeutics INC | $166.72 | 2023-2025 | Accrufer |
| Sumitomo Pharma America, INC. | $104.70 | 2023-2025 | Myfembree |
| Exact Sciences Corporation | $104.04 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Davol INC. | $86.28 | 2023-2025 | Arista, Arista Ah Flexitip |
| Sage Therapeutics, LLC | $82.38 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $80.70 | 2023-2024 | Slynd |
| Gynesonics, INC. | $79.23 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $40.42 | 2024-2025 | Myosure Tissue Removal Device |
| Novo Nordisk INC | $36.49 | 2025 | Rybelsus, Ozempic |
| Organogenesis INC. | $20.13 | 2025 | Cygnus Dual |
| Vertex Pharmaceuticals Incorporated | $19.84 | 2025 | |
| Recordati_rare_diseases_inc. | $18.32 | 2025 | Isturisa |
| Evofem Biosciences, INC. | $18.11 | 2025 | Phexxi, Solosec, Phexx |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $17.85 | 2025 | Unithroid |
| Bayer Healthcare Pharmaceuticals INC. | $16.91 | 2023 | |
| Ibsa Pharma INC. | $16.88 | 2025 | Tirosint, Flector, Licart |
| Glaxosmithkline, LLC. | $16.16 | 2025 | Shingrix, Arexvy |
| Coopersurgical, INC. | $15.70 | 2025 | Paragard T 380a |
| Supernus Pharmaceuticals, INC. | $15.21 | 2025 | Qelbree |
| Abbvie INC. | $13.59 | 2023 | Lo Loestrin Fe |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Youssef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.